Löffler endocarditis: a rare cause of acute cardiac failure

Journal of Cardiothoracic Surgery

Nardo JM van der Meer¹  Olaf JL Loosveld²  Frans BS Oei⁴  Kadir Caliskan⁵  Paul LA van Daele³  Nicolasine D Niemeijer² 

[1] Department of Anaesthesiology and Intensive Care Medicine, Amphia Hospital, Breda and Oosterhout, the Netherlands;Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands;Department of Internal Medicine, Erasmus Medical Centre, Rotterdam, the Netherlands, P.O. Box 2040, , 3000, CA, Rotterdam, the Netherlands;Department of Cardio-Thoracic Surgery, Erasmus Medical Centre, Rotterdam, the Netherlands;Department of Cardiology, Erasmus Medical Centre, Rotterdam, the Netherlands

关键词: Löffler endocarditis;    Cardiac failure;    Cardiac thrombus;    Hypereosinophilic syndrome;   

Others  :  1152665
DOI  :  10.1186/1749-8090-7-109

 received in 2012-04-02, accepted in 2012-09-25,  发布年份 2012

【 摘 要 】

We describe a patient with acute cardiogenic shock due to cardiac involvement in idiopathic hypereosinophilic syndrome (Löffler endocarditis). At the echocardiography, there was a huge mass in the left ventricular cavity, resulting in inflow- and outflow tract obstruction. The posterior leaflet of the mitral valve apparatus was completely embedded in a big (organized) thrombus mass. The patient was treated with high dose corticosteroids, however without effect. Partial remission was achieved after treatment with hydroxycarbamide. He was also treated with anticoagulants and high dose beta-blockers. The patient’s condition improved remarkably after correction of the mitral valve insufficiency by a mitral valve bioprosthesis.

【 授权许可】

   
2012 Niemeijer et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Chusid MJ, Dale DC, West BC, Wolff SM: The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975, 54:1-27.
• [2]Tefferi A, Patnaik MM, Pardanani A: Eosinophilia: secondary, clonal and idiopathic. Br J Haematol 2006, 133:468-492.
• [3]Weller PF, Bubley GJ: The idiopathic hypereosinophilic syndrome. Blood 1994, 83:2759-2779.
• [4]Cincin AA, Ozben B, Tanrikulu MA, Baskan O, Agirbasli M: Large apical thrombus in a patient with persistent heart failure and hypereosinophilia: Loffler endocarditis. J Gen Intern Med 2008, 23:1713-1718.
• [5]Roufosse F, Cogan E, Goldman M: The hypereosinophilic syndrome revisited. Annu Rev Med 2003, 54:169-184.
• [6]Fuzellier JF, Chapoutot L, Torossian PF, Metz D, Baehrel B: Mitral valve replacement in idiopathic eosinophilic endocarditis without peripheral eosinophilia. J Card Surg 2005, 20:472-474.
• [7]Sasano H, Virmani R, Patterson RH, Robinowitz M, Guccion JG: Eosinophilic products lead to myocardial damage. Hum Pathol 1989, 20:850-857.
• [8]Hendren WG, Jones EL, Smith MD: Aortic and mitral valve replacement in idiopathic hypereosinophilic syndrome. Ann Thorac Surg 1988, 46:570-571.
• [9]Tanino M, Kitamura K, Ohta G, Yamamoto Y, Sugioka G: Hypereosinophilic syndrome with extensive myocardial involvement and mitral valve thrombus instead of mural thrombi. Acta Pathol Jpn 1983, 33:1233-1242.
• [10]Benezet-Mazuecos J, Marcos-Alberca P, Farre J, Orejas M, de la Fuente A, Prieto E: Early differential resolution of right and left ventricular obliteration in Löffler endocarditis after chemotherapy and anticoagulation. Circulation 2006, 114:e635-e637.
• [11]ten Oever J, Theunissen LJHJ, Tick LW, Verbunt RJAM: Cardiac involvement in hypereosinophilic syndrome. Neth J Med 2011, 69:240-244.
• [12]Bozcali E, Aliyev F, Agac MT, Erkan H, Okcun B, Babalik E, Karpuz H: Unusual case of aortic valve involvement in patient with Loffler’s endomyocarditis: management, follow-up and short review of the literature. J Thromb Thrombolysis 2007, 24:309-313.
• [13]Yoon TY, Ahn GB, Chang SH: Complete remission of hypereosinophilic syndrome after interferon-alpha therapy: report of a case and literature review. J Dermatol 2000, 27:110-115.
• [14]Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH: NIH conference. the idiopathic hypereosinophilic syndrome. clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982, 97:78-92.
• [15]Tefferi A: Modern diagnosis and treatment of primary eosinophilia. Acta Haematol 2005, 114:52-60.
• [16]Kahn JE, Bletry O, Guillevin L: Hypereosinophilic syndromes. Best Pract Res Clin Rheumatol 2008, 22:863-882.
• [17]Antoniu SA: Novel therapies for hypereosinophilic syndromes. Neth J Med 2010, 68:304-310.
• [18]Wilkins HJ, Crane MM, Copeland K, Williams WV: Hypereosinophilic syndrome: an update. Am J Hematol 2005, 80:148-157.
• [19]Ueno NT, Anagnostopoulos A, Rondón G, Champlin RE, Mikhailova N, Pankratova OS, Zoubarovskaya LS, Semenova EV, Afanasyev BV, O’Brien S, Andreeff M, Zaritskey AY: Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome. Br J Haematol 2002, 119:131-134.
• [20]Cooper MA, Akard LP, Thompson JM, Dugan MJ, Jansen J: Hypereosinophilic syndrome: long-term remission following allogeneic stem cell transplant in spite of transient eosinophilia post-transplant. Am J Hematol 2005, 78:33-36.
• [21]Boustany CW Jr, Murphy GW, Hicks GL Jr: Mitral valve replacement in idiopathic hypereosinophilic syndrome. Ann Thorac Surg 1991, 51:1007-1009.